BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 26966056)

  • 1. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals.
    Turner JP; Edwards S; Stanners M; Shakib S; Bell JS
    BMJ Open; 2016 Mar; 6(3):e009781. PubMed ID: 26966056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
    Palagyi A; Keay L; Harper J; Potter J; Lindley RI
    BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are residents of aged care facilities willing to have their medications deprescribed?
    Kalogianis MJ; Wimmer BC; Turner JP; Tan EC; Emery T; Robson L; Reeve E; Hilmer SN; Bell JS
    Res Social Adm Pharm; 2016; 12(5):784-8. PubMed ID: 26850702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
    Bolmsjö BB; Palagyi A; Keay L; Potter J; Lindley RI
    BMC Fam Pract; 2016 Nov; 17(1):152. PubMed ID: 27814691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia.
    Baysari MT; Duong M; Zheng WY; Nguyen A; Lo S; Ng B; Ritchie A; Le Couteur D; McLachlan A; Bennett A; Hilmer S
    BMJ Open; 2019 Sep; 9(9):e030950. PubMed ID: 31562155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negotiating "Unmeasurable Harm and Benefit": Perspectives of General Practitioners and Consultant Pharmacists on Deprescribing in the Primary Care Setting.
    Anderson K; Foster M; Freeman C; Luetsch K; Scott I
    Qual Health Res; 2017 Nov; 27(13):1936-1947. PubMed ID: 29088989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
    Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
    Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.
    Kouladjian L; Gnjidic D; Reeve E; Chen TF; Hilmer SN
    Ann Pharmacother; 2016 Aug; 50(8):625-36. PubMed ID: 27257284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prioritizing interventions to manage polypharmacy in Australian aged care facilities.
    Jokanovic N; Wang KN; Dooley MJ; Lalic S; Tan EC; Kirkpatrick CM; Bell JS
    Res Social Adm Pharm; 2017; 13(3):564-574. PubMed ID: 27374998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study.
    Kua CH; Mak VS; Lee SWH
    BMJ Open; 2019 Oct; 9(10):e030106. PubMed ID: 31604786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.
    Jungo KT; Mantelli S; Rozsnyai Z; Missiou A; Kitanovska BG; Weltermann B; Mallen C; Collins C; Bonfim D; Kurpas D; Petrazzuoli F; Dumitra G; Thulesius H; Lingner H; Johansen KL; Wallis K; Hoffmann K; Peremans L; Pilv L; Šter MP; Bleckwenn M; Sattler M; van der Ploeg M; Torzsa P; Kánská PB; Vinker S; Assenova R; Bravo RG; Viegas RPA; Tsopra R; Pestic SK; Gintere S; Koskela TH; Lazic V; Tkachenko V; Reeve E; Luymes C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2021 Jan; 21(1):19. PubMed ID: 33413142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to Deprescribing Psychotropic Medications for Changed Behaviours in Long-Term Care Residents Living with Dementia.
    Harrison SL; Cations M; Jessop T; Hilmer SN; Sawan M; Brodaty H
    Drugs Aging; 2019 Feb; 36(2):125-136. PubMed ID: 30535930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "… Above All, It's a Matter of  This Person's Quality of Life": Health Care Professionals' Perspectives on Deprescribing in Older Patients With Limited Life Expectancy.
    Lundby C; Graabæk T; Ryg J; Søndergaard J; Pottegård A; Nielsen DS
    Gerontologist; 2020 Apr; 60(3):439-449. PubMed ID: 31433836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and Enablers of Deprescribing: A General Practitioner Perspective.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    PLoS One; 2016; 11(4):e0151066. PubMed ID: 27093289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study.
    Mantelli S; Jungo KT; Rozsnyai Z; Reeve E; Luymes CH; Poortvliet RKE; Chiolero A; Rodondi N; Gussekloo J; Streit S
    BMC Fam Pract; 2018 Oct; 19(1):169. PubMed ID: 30314468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
    Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
    Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiences of recently relocated residents of a long-term care facility in Ontario: assessing quality qualitatively.
    Coughlan R; Ward L
    Int J Nurs Stud; 2007 Jan; 44(1):47-57. PubMed ID: 16413555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.